Changing the rhythm of dysrhythmia education through blended learning.

Costanzo AJ, Ehrhardt B, Gormly DK

Genetic variations in IL6 and IL12B decreasing the risk for psoriasis.

Boca AN, Talamonti M, Galluzzo M, Botti E, Vesa SC, Chimenti S, Buzoianu AD, Costanzo A

Living matter observations with a novel hyperspectral supercontinuum confocal microscope for VIS to near-IR reflectance spectroscopy.

Bertani FR, Ferrari L, Mussi V, Botti E, Costanzo A, Selci S

Effects of prolonged wakefulness: the role of PERIOD3 genotypes and personality traits.

Barbato G, Costanzo A, Della Monica C, D'Onofrio P, Cerrato F, De Padova V

Ustekinumab treatment of erythrodermic psoriasis occurring after physical stress: a report of two cases.

Saraceno R, Talamonti M, Galluzzo M, Chiricozzi A, Costanzo A, Chimenti S

The mechanistic basis for psoriasis immunopathogenesis: translating genotype to phenotype. Report of a workshop, Venice, 2012.

Bachelez H, Viguier M, Tebbey PW, Lowes M, Suárez-Fariñas M, Costanzo A, Nestle FO

Pharmacogenetics of psoriasis: HLA-Cw6 but not LCE3B/3C deletion nor TNFAIP3 polymorphism predisposes to clinical response to interleukin 12/23 blocker ustekinumab.

Talamonti M, Botti E, Galluzzo M, Teoli M, Spallone G, Bavetta M, Chimenti S, Costanzo A

Synthesis of novel cognition enhancers with pyrazolo[5,1-c][1,2,4]benzotriazine core acting at γ-aminobutyric acid type A (GABA(A)) receptor.

Guerrini G, Ciciani G, Costanzo A, Daniele S, Martini C, Ghelardini C, Di Cesare Mannelli L, Ciattini S

Long-term ustekinumab treatment for refractory type I pityriasis rubra pilaris.

Di Stefani A, Galluzzo M, Talamonti M, Chiricozzi A, Costanzo A, Chimenti S

p63 is an alternative p53 repressor in melanoma that confers chemoresistance and a poor prognosis.

Matin RN, Chikh A, Chong SL, Mesher D, Graf M, Sanza' P, Senatore V, Scatolini M, Moretti F, Leigh IM, Proby CM, Costanzo A, Chiorino G, Cerio R, Harwood CA, Bergamaschi D